News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Derma Sciences, Inc. (DSCI) Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion And Progress In Launching New Placental-Derived Tissue Products


3/14/2014 7:11:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ended December 31, 2013. Highlights of the fourth quarter of 2013 and recent weeks include:

•Expanded the Advanced Wound Care (AWC) product line and entered the $500 million skin substitute market by licensing the AMNIO family of placental-derived tissue products

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES